These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32910548)

  • 1. Landscape of associations between long non-coding RNAs and infiltrating immune cells in liver hepatocellular carcinoma.
    Li L; Song X; Lv Y; Jiang Q; Fan C; Huang D
    J Cell Mol Med; 2020 Oct; 24(19):11243-11253. PubMed ID: 32910548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
    Yu X; Zhang J; Yang R; Li C
    Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma.
    Kong R; Wang N; Zhou CL; Lu J
    J Microbiol Biotechnol; 2024 Apr; 34(4):958-968. PubMed ID: 38494878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
    Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
    Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparse Independence Component Analysis for Competitive Endogenous RNA Co-Module Identification in Liver Hepatocellular Carcinoma.
    Shi Y; Zhou L; Zeng W; Wei B; Deng J
    IEEE J Transl Eng Health Med; 2023; 11():384-393. PubMed ID: 37465460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA F11-AS1 suppresses liver hepatocellular carcinoma progression by competitively binding with miR-3146 to regulate PTEN expression.
    Du J; Chen M; Liu J; Hu P; Guan H; Jiao X
    J Cell Biochem; 2019 Oct; 120(10):18457-18464. PubMed ID: 31168823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma.
    Yue Y; Tao J; An D; Shi L
    Heliyon; 2024 Jan; 10(2):e24462. PubMed ID: 38293480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    Gao B; Zhang X; Huang Y; Yang Z; Zhang Y; Zhang W; Gao ZH; Xue D
    PLoS One; 2017; 12(3):e0174142. PubMed ID: 28355233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
    Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
    Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
    Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H
    J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma.
    Zhu R; Guo W; Xu XJ; Zhu L
    Comput Math Methods Med; 2020; 2020():8872329. PubMed ID: 33204302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32579175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma.
    Lou X; Li J; Yu D; Wei YQ; Feng S; Sun JJ
    Cancer Med; 2019 Sep; 8(12):5735-5749. PubMed ID: 31392826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Wang J; Pu J; Yao T; Lu X; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.